Tokyo, July 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058577) titled 'Effects of Branched-Chain Amino Acid Supplementation on Central Fatigue' on July 24.

Study Type: Interventional

Study Design: Basic Design - Cross-over Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo

Primary Sponsor: Institute - Health Sciences University of Hokkaido

Condition: Condition - young healthy adults Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - This study aims to clarify whether branched-chain amino acids supplementation reduces subjective fatigue, task performance decline, and scores on subjective fatigue-related rating scales in young healthy individuals experiencing central fatigue induced by cognitive tasks. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Participants will consume each of the following test beverages, which are widely available as general food products, once each. Fifteen minutes after ingestion, a 30-minute central fatigue-inducing task will be performed. BCAA beverage: 2000 mg of branched-chain amino acids (BCAAs) in granule form dissolved in 200 mL of water. Interventions/Control_2 - Participants will consume each of the following test beverages, which are widely available as general food products, once each. Fifteen minutes after ingestion, a 30-minute central fatigue-inducing task will be performed. Placebo beverage: A beverage with similar caloric content but without BCAAs, dissolved in 200 mL of water.

Eligibility: Age-lower limit - 18 years-old

Gender - Male and Female Key inclusion criteria - 1.Individuals aged 18 years or older and under 25 years, with no health problems. 2.Individuals who have received a full explanation of the study, sufficiently understood the contents, and voluntarily provided informed consent to participate. Key exclusion criteria - 1.Individuals with a history of allergies or other medical conditions related to dairy products. 2.Individuals with any current medical conditions under treatment. 3.Individuals who regularly take medications or supplements that may affect concentration. 4.Any other individuals deemed inappropriate as study participants by the principal investigator. Target Size - 50

Recruitment Status: Recruitment status - Open public recruiting Date of protocol fixation - 2025 Year 07 Month 18 Day Date of IRB - 2025 Year 07 Month 24 Day Anticipated trial start date - 2025 Year 07 Month 24 Day Last follow-up date - 2027 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066899

Disclaimer: Curated by HT Syndication.